Alto v. Sun Pharmaceutical Industries, Inc.

Background

The parties jointly requested a protective order under Federal Rule of Civil Procedure 26(c). They sought protection for nonpublic and competitively sensitive information that might be disclosed during discovery. The court found good cause for an appropriately limited confidentiality order governing the pretrial phase of the action.

What the Order Covers

The order applies to the parties, their officers, agents, employees, attorneys, certain people acting with them, and anyone with actual notice of the order. It covers discovery material designated as “Confidential.” A producing party may designate only material that it reasonably and in good faith believes includes categories such as previously undisclosed financial information, information about ownership or control of a nonpublic company, business or marketing plans, product-development information, or personal or intimate information.

The order explains how confidential designations must be made. For most discovery material, the protected portions must be clearly marked, and the producing party must provide a version with the confidential information redacted for future public use. Deposition testimony and exhibits may be designated during the deposition or within 30 days afterward. During that 30-day period, the entire deposition transcript must be treated as confidential.

A producing party may later correct an inadvertent failure to designate material as confidential by notifying the other parties and providing replacement versions within two business days. The order does not waive objections to discovery, privilege, or other protections, and it does not decide whether documents or testimony will be admissible at trial.

Permitted Disclosures and Use

Confidential material may be disclosed only to specified recipients, including the parties and their insurers, counsel and counsel’s assigned staff, outside vendors working on the case, mediators or arbitrators, people identified on a document as its author or recipient, potential witnesses, experts and other specialized advisers, deposition transcribers, and the court. Witnesses, experts, mediators, arbitrators, and certain other recipients must first receive the order and sign a nondisclosure agreement.

Recipients may use confidential material only to prosecute or defend this action and related appeals. The order does not restrict a party’s rights concerning its own documents or information. A party may produce confidential material in response to a subpoena or other legal requirement, but must provide notice to the producing party as soon as reasonably possible and, when allowed, at least 10 days before disclosure.

Court Filings, Challenges, and Enforcement

When confidential material is filed with the court, the parties must publicly file a redacted version and file the unredacted version under seal. A party seeking sealing must submit an application and supporting declaration explaining, on a particularized basis, why sealing is justified. The order warns that the court is unlikely to seal material introduced at trial merely because it was previously designated confidential.

A party may object to a confidentiality designation or request additional disclosure limits, such as attorneys’-eyes-only treatment, before trial. If the parties cannot resolve the dispute, they must bring it to the court under the court’s individual practices. Most recipients must return or destroy confidential material within 60 days after final disposition of the action, including appeals, and certify that they retained no copies or summaries. Lawyers specifically retained for the action may keep archival copies of certain case materials, but those copies remain subject to the order.

Ruling

Judge Gregory H. Woods ordered the parties and other covered persons to follow the stipulated confidentiality agreement and protective order. The order will remain binding after the litigation ends, and the court retained jurisdiction to enforce its obligations and impose contempt sanctions for violations. This order addressed discovery confidentiality and did not resolve the underlying claims.